使用 Merative MarketScan 研究数据库检测药物安全信号的活性比较器进行自我控制的案例系列的性能
Astrid Coste1, Angel Y S Wong1, Francois Haguinet2
1Department of Non-Communicable Diseases Epidemiology, LSHTM, London, UK.
Pharmacoepidemiology and drug safety
|November 11, 2025
概括
自主控制案例系列 (SCCS) 方法在索赔数据库中显示药物安全信号检测的希望. 虽然主动比较器提高了特异性,但它们降低了SCCS方法的整体性能.
科学领域:
- 药物监督 药物监督 药物监督
- 现实世界的数据分析.
- 流行病学方法 流行病学方法
背景情况:
- 美国索赔数据库在常规药物安全信号检测中未得到充分利用.
- 自控案例系列 (SCCS) 是分析真实世界数据 (RWD) 的关键方法.
- 积极的比较器可以通过通过指示解决混来增强SCCS.
研究的目的:
- 评估自控案例系列 (SCCS) 的表现,使用和不使用活跃的比较器.
- 评估美国商业市场的信号检测能力,扫描商业索赔和医疗保险数据库.
主要方法:
- 将SCCS应用于宏类和诺基诺类抗生素,使用阿莫西西林和塞法列辛作为活性比较剂.
- 使用了104个阳性和58个阴性药物结果对照的参考组.
- 测量了2年的诊断性能 (灵敏度,特异性),具有30天的风险窗口.
主要成果:
- 没有活性比较器的SCCS产生了0.73/0.72的灵敏度和0.68/0.62.62的特异性.
- 活性对比剂增加了特异性至0.84/0.86,但降低了对0.45/0.36.的敏感性.
- 在商业和医疗保险索赔数据中评估了绩效.
结论:
- 市场扫描数据库适用于药物安全信号检测.
- 通过精心设计的参考设置,SCCS表现出与最佳设置相当的性能.
- 主动比较器提高了特异性,但通过降低灵敏度降低了SCCS总体性能.
更多相关视频
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
18.2K
07:35Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
7.9K
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Hazard Ratio
554
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
554
Therapeutic Drug Monitoring: Drug Analysis Methods
168
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
168
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
392
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
392
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
